Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06029309 |
Title | Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma (ZANU-TAFA) |
Acronym | ZANU-TAFA |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Alvaro Alencar, MD |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |